Positioning filgotinib in the treatment algorithm of moderate to severe ulcerative colitis
F D'Amico, F Magro, L Peyrin-Biroulet… - Journal of Crohn's and …, 2022 - academic.oup.com
Abstract Background and Aims Filgotinib is a small molecule that selectively inhibits Janus
kinase [JAK] type 1. It is already approved for the treatment of rheumatoid arthritis and is …
kinase [JAK] type 1. It is already approved for the treatment of rheumatoid arthritis and is …
[HTML][HTML] Positioning Filgotinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis
F D'Amico, F Magro, L Peyrin-Biroulet… - Journal of Crohn's & …, 2022 - ncbi.nlm.nih.gov
Methods The Pubmed, Embase and Scopus databases were searched up to June 25, 2021
in order to identify studies reporting efficacy and safety data of filgotinib in patients with UC …
in order to identify studies reporting efficacy and safety data of filgotinib in patients with UC …
Positioning Filgotinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis.
F D'Amico, F Magro, L Peyrin-Biroulet… - Journal of Crohn's & …, 2022 - search.ebscohost.com
Abstract Background and Aims Filgotinib is a small molecule that selectively inhibits Janus
kinase [JAK] type 1. It is already approved for the treatment of rheumatoid arthritis and is …
kinase [JAK] type 1. It is already approved for the treatment of rheumatoid arthritis and is …
[PDF][PDF] Positioning Filgotinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis
F D'Amico, F Magro, L Peyrin-Biroulet… - Journal of Crohn's and …, 2022 - academic.oup.com
Abstract Background and Aims Filgotinib is a small molecule that selectively inhibits Janus
kinase [JAK] type 1. It is already approved for the treatment of rheumatoid arthritis and is …
kinase [JAK] type 1. It is already approved for the treatment of rheumatoid arthritis and is …
Positioning Filgotinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis.
F D'Amico, F Magro, L Peyrin-Biroulet… - Journal of Crohn's & …, 2022 - europepmc.org
Methods The Pubmed, Embase and Scopus databases were searched up to June 25, 2021
in order to identify studies reporting efficacy and safety data of filgotinib in patients with UC …
in order to identify studies reporting efficacy and safety data of filgotinib in patients with UC …
Positioning Filgotinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis
F D'Amico, F Magro… - Journal of Crohn's & …, 2022 - pubmed.ncbi.nlm.nih.gov
Background and aims Filgotinib is a small molecule that selectively inhibits Janus kinase
[JAK] type 1. It is already approved for the treatment of rheumatoid arthritis and is being …
[JAK] type 1. It is already approved for the treatment of rheumatoid arthritis and is being …
[PDF][PDF] Positioning Filgotinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis
F D'Amico, F Magro… - Journal of Crohn's …, 2022 - pdfs.semanticscholar.org
Abstract Background and Aims: Filgotinib is a small molecule that selectively inhibits Janus
kinase [JAK] type 1. It is already approved for the treatment of rheumatoid arthritis and is …
kinase [JAK] type 1. It is already approved for the treatment of rheumatoid arthritis and is …
Positioning Filgotinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis
F d'Amico, F Magro, L Peyrin-Biroulet… - Journal of Crohn's …, 2022 - hal.univ-lorraine.fr
Abstract Background and Aims Filgotinib is a small molecule that selectively inhibits Janus
kinase [JAK] type 1. It is already approved for the treatment of rheumatoid arthritis and is …
kinase [JAK] type 1. It is already approved for the treatment of rheumatoid arthritis and is …
Positioning Filgotinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis
F D'Amico, F Magro, L Peyrin-Biroulet… - Journal of Crohn's and …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background and Aims</jats:
title>< jats: p> Filgotinib is a small molecule that selectively inhibits Janus kinase [JAK] type …
title>< jats: p> Filgotinib is a small molecule that selectively inhibits Janus kinase [JAK] type …